Participating in international research programs means broadening the horizons of innovation and collaborating with leading international centers to improve diagnoses, treatments, and patients’ quality of life. On this page, we present the projects to which the Institute contributes its scientific and clinical expertise.
The European Comprehensive Cancer Centre Network
EUNetCCC
Status: Active
Number: EU4H-2022-PJ-06
Principal Investigator: Gregorc
Funding Allocated: €659,811.69
Implementing inter-specialty cancer training in 100 centers across Europe
INTERACT-EUROPE 100
Status: Active
Number: EU4H-2022-PJ-06
Principal Investigator: Various
Allocated funding: N/A
Turin Lyon Against Cancer
TL2C (ALCOTRA)
Status: Active
Number: 20126
Principal Investigator: Sapino
Funding Allocated: €998,200.00
Metrology for genomic profiling to support early cancer detection and precision medicine
GenomeMET
Status: Active
Number: https://www.genomemet.org/
Principal Investigator: Venesio
Funding allocated: €120,000.00
Comprehensive Cancer Infrastructures 4 Europe
CCI4EU
Status: Completed
Number: https://cci4eu.eu/
Principal Investigator: Gregorc
Funding Allocated: €28,625.00
Leveraging DNA repair and metabolic vulnerabilities to advance novel pharmacogenomics strategies
METAPRO
Status: Active
Number:
Principal Investigator: Arena
Funding Allocated: €399,850.00
An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
ProCAncer-I
Status: Completed
Number: H2020-SC1-FA-DTS-2018-2020
Principal Investigator: Regge
Allocated funding: €1,122,812.50
Integrated and standardized NGS workflows for personalized therapy
INSTAND-NGS4P
Status: Completed
Number: https://www.instandngs4p.eu/
Principal Investigators: Marchiò and Sapino
Allocated funding: €6,390.00